Table 2.
Genotype | Ncontrol/Ncase | Univariate analysis | Multivariate analysis* | ||
---|---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | ||
FBXO32 rsl0093411 A>G | |||||
AA | 13782/15954 | 1.00 | 1.00 | ||
AG | 8967/10850 | 1.05 (1.01–1.08) | 0.016 | 1.05 (1.01–1.09) | 0.010 |
GG | 1500/1949 | 1.12 (1.05–1.21) | 0.002 | 1.13 (1.05–1.21) | 0.001 |
Trend test | 0.0003 | 0.0002 | |||
AG+GG | 10467/12799 | 1.06 (1.02–1.09) | 0.002 | 1.06 (1.02–1.10) | 0.001 |
FOXO6 rs61229336 OT | |||||
CC | 10434/12758 | 1.00 | 1.00 | ||
CT | 10956/12778 | 0.95 (0.92–0.99) | 0.011 | 0.96 (0.92–0.99) | 0.015 |
TT | 2859/3217 | 0.92 (0.87–0.97) | 0.004 | 0.92 (0.87–0.97) | 0.004 |
Trend test | 0.0009 | 0.001 | |||
CT+TT | 13815/15995 | 0.95 (0.92–0.98) | 0.002 | 0.95 (0.92–0.98) | 0.003 |
FBXO32 rs62521280 C>T | |||||
CC | 19400/22590 | 1.00 | 1.00 | ||
CT | 4535/5801 | 1.10 (1.05–1.15) | <0.0001 | 1.10 (1.05–1.14) | <0.0001 |
TT | 314/362 | 0.99 (0.85–1.15) | 0.898 | 0.99 (0.85–1.16) | 0.909 |
Trend test | 0.0003 | 0.0005 | |||
CT+TT | 4849/6163 | 1.09 (1.05–1.14) | <0.0001 | 1.09 (1.04–1.14) | 0.0001 |
Number of combined risk genotypes † | |||||
0 | 6519/7378 | 1.00 | 1.00 | ||
1 | 10789/12517 | 1.03 (0.98–1.07) | 0.249 | 1.02 (0.98–1.07) | 0.270 |
2 | 5862/7371 | 1.11 (1.06–1.17) | <0.0001 | 1.11 (1.06–1.16) | <0.0001 |
3 | 1079/1487 | 1.22 (1.12–1.33) | <0.0001 | 1.22 (1.11–1.33) | <0.0001 |
Trend test | <0.0001 | <0.0001 | |||
0–1 | 17308/19895 | 1.00 | 1.00 | ||
2–3 | 6941/8858 | 1.11 (1.07–1.15) | <0.0001 | 1.11 (1.07–1.15) | <0.0001 |
Abbreviations: BC: breast cancer; CI: confidence interval; DRIVE: Discovery, Biology, and Risk of Inherited Variants in Breast Cancer; FBXO32, F-box protein 32; FOXO: Forkhead box O; FOXO6, Forkhead box O6; OR: odd ratio; SNP: single nucleotide polymorphism.
Adjusted for age, PC1, PC3, PC4, PC5, PC6, PC8, PC10, PC11, PC14 and PC16.
Risk genotypes were rs10093411 AG+GG, rs61229336 CC and rs62521280 CT+TT.